KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Change in Cash: 2009-2025

Historic Change in Cash for Dynavax Technologies (DVAX) over the last 15 years, with Sep 2025 value amounting to $61.1 million.

  • Dynavax Technologies' Change in Cash rose 793.82% to $61.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.9 million, marking a year-over-year increase of 216.42%. This contributed to the annual value of -$54.4 million for FY2024, which is 5.32% down from last year.
  • Dynavax Technologies' Change in Cash amounted to $61.1 million in Q3 2025, which was up 28.99% from $47.4 million recorded in Q2 2025.
  • Dynavax Technologies' 5-year Change in Cash high stood at $189.8 million for Q4 2021, and its period low was -$256.8 million during Q1 2022.
  • For the 3-year period, Dynavax Technologies' Change in Cash averaged around -$3.8 million, with its median value being -$18.3 million (2024).
  • As far as peak fluctuations go, Dynavax Technologies' Change in Cash spiked by 31,529.30% in 2021, and later crashed by 646.66% in 2022.
  • Dynavax Technologies' Change in Cash (Quarterly) stood at $189.8 million in 2021, then tumbled by 98.18% to $3.4 million in 2022, then tumbled by 222.49% to -$4.2 million in 2023, then plummeted by 455.75% to -$23.5 million in 2024, then spiked by 793.82% to $61.1 million in 2025.
  • Its Change in Cash stands at $61.1 million for Q3 2025, versus $47.4 million for Q2 2025 and -$44.2 million for Q1 2025.